The Argus II retinal prosthesis system restored some basic visual function at 5 years after implantation in patients who were blind from retinitis pigmentosa or outer retinal degeneration, according to a study. The prospective, multicenter, single-arm …
Author: Healio ophthalmology
Five most-read OSN blogs in July
OSN bloggers share their opinions on ophthalmology’s hottest topics. This month, topics ranged from the FDA approval of Shire’s lifitegrast ophthalmic solution to a surgical technique video demonstrating the treatment of a patient with pseudophacocele.
Abbott second quarter worldwide sales increase to $5.3 billion
Abbott reported net sales of $5.3 billion in the second quarter, a 3.2% increase on a reported basis and a 6.4% increase on an operational basis from a year ago, according to a press release.Net earnings totaled $615 million compared with $784 million …
VIDEO: Indications, benefits of amniotic membrane transplantation
At Kiawah Eye, Charlene M. Grice, MD, talks about the advantages and disadvantages of amniotic membrane transplantation.
Half-dose or half-time PDT improves visual acuity, reduces subretinal fluid
Half-dose and half-time fluorescein angiography-guided photodynamic therapy yielded similar visual and anatomic results in the treatment of central serous chorioretinopathy, a study found.The retrospective case series included 61 eyes with acute or chr…
Publication Exclusive: Intraocular antibiotic prophylaxis in best interests of patients
During my residency and fellowship training in the 1970s, the two most dreaded complications of cataract surgery were expulsive choroidal hemorrhage and endophthalmitis. In advanced countries, expulsive choroidal hemorrhage has been nearly eliminated a…
Novartis reports $12.5 billion in net sales in second quarter
Novartis reported $12.5 billion in net sales in the second quarter compared with $12.7 billion in the same quarter of 2015, according to a press release. Operating income was reported at $2.1 billion in the second quarter compared with $2.3 billion in …
VIDEO: OCT screening before cataract surgery eliminates postoperative visual surprises
At Kiawah Eye, Steve Charles, MD, encourages surgeons to perform OCT screening in patients before cataract surgery to avoid postoperative visual surprises.
Intraoperative spectral-domain OCT provides reliable imaging of IOL position
Intraoperative spectral-domain OCT was successful in imaging IOL position during standard phacoemulsification, a study found.The prospective study included 101 eyes of 74 patients who underwent standard phacoemulsification and IOL implantation.
GenSight Biologics becomes first gene therapy company listed in Europe
GenSight Biologics has become the first gene therapy company to be listed in Europe following an initial public offering on Euronext Paris, according to company correspondence.GenSight, founded in 2012 and based in Paris, focuses on the discovery and d…
In memory of Prof. Kazuichi Konyama, 1928 to 2016
It is with great sadness that we announce the passing of Prof. Kazuichi Konyama, a great leader and mentor of ophthalmology in Japan and Thailand and around the Asia-Pacific region.Although Prof. Konyama was born in Kagawa, Japan, he began his medical training in Thailand in the 1950s. In 1960, he received a doctorate from Juntendo University in Tokyo, where he was later an instructor. He also completed a master’s degree in public health from Johns Hopkins University in 1982.
Santen to acquire InnFocus
Santen Pharmaceutical announced it has entered into a definitive agreement to acquire InnFocus, developer of the MicroShunt glaucoma implant device.Santen will acquire InnFocus for an upfront payment of $225 million, plus performance-based consideratio…
Study: Epithelium-on cross-linking not yet hitting goal
Removal of the epithelium is still a crucial step in the cross-linking procedure, according to a study recently published in the Journal of Refractive Surgery.“The modified riboflavin solution containing benzalkonium chloride (BAC-EDTA), which raised hope for the epithelium-on procedure in preclinical studies, has had disappointing results in human,” Farhad Hafezi, MD, PhD, principal investigator, told Ocular Surgery News.
Trachoma elimination moves one step closer with Global Trachoma Mapping Project
A 3-year disease mapping project screening 2.6 million people in 29 countries worldwide provided an unprecedented amount of data on the magnitude, geographic distribution and burden of trachoma. In addition, it is now giving further impetus to the impl…
FDA approves Avedro’s cross-linking system for corneal ectasiafollowing refractive surgery
The FDA has approved the KXL system and two photoenhancers for the treatment of corneal ectasia following refractive surgery, according to an Avedro press release. The KXL system and the two photoenhancers, Photrexa 0.146% (riboflavin 5’-phosphate ophthalmic solution) and Photrexa Viscous 0.146% (riboflavin 5’-phosphate in 20% dextran ophthalmic solution), previously received FDA approval in April for the treatment of progressive keratoconus.
TPG Capital to acquire Beaver-Visitec
TPG Capital has entered into a definitive agreement with RoundTable Healthcare Partners to acquire Beaver-Visitec, according to a RoundTable press release. The transaction will include brands of Beaver blades, Visitec cannulae and instruments, Merocel …
As-needed aflibercept resolves persistent, recurrent fluid in eyes with neovascular AMD
As-needed aflibercept injections improved anatomic outcomes in eyes with recurrent or persistent retinal fluid associated with neovascular age-related macular degeneration, a study found.The retrospective study included 81 eyes of 78 patients with pers…
Allergan submits application to FDA for Oculeve intranasal tear neurostimulator
Allergan has filed a de novo application to the FDA for the Oculeve intranasal tear neurostimulator, according to a company press release. The hand-held stimulator can temporarily increase tear production in patients with dry eye disease due to decreas…
Five most-viewed videos from EGS
The most trending articles on Healio.com/OSN from the European Glaucoma Society Congress were video perspectives from key opinion leaders who shared their perspectives on trending topics related to glaucoma treatment.
VIDEO: Speaker talks use of spot vision screener on patients with developmental disability
At Kiawah Eye, Amanda Limbaugh Marzolf, MD, discusses results of a study looking at the prevalence of amblyopia risk factors in patients with developmental disability with the use of the spot vision screener.